Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.

Semaglutide prescription initiation predictors included female sex and use of antidepressants among patients with obesity without diabetes.

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...